Literature DB >> 13061238

Arterenol in treatment of shock.

A J MILLER, A SHIFRIN, B M KAPLAN, H GOLD, A BILLINGS, L N KATZ.   

Abstract

Entities:  

Keywords:  ARTERENOL/therapeutic use; SHOCK/therapy

Mesh：

Substances：

Year:  1953        PMID： 13061238     DOI： 10.1001/jama.1953.03690130014003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  7 in total

1.  CLINICAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION.

Authors:  F W HURLBURT; J G GILLIS; D KAVANAGH-GRAY; R A PALMER; B SHALLARD; J A TRAYNOR
Journal:  Can Med Assoc J       Date:  1965-08-28       Impact factor: 8.262

2.  STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN.

Authors:  J N COHN; M H LURIA
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

3.  Noradrenaline in shock due to visceral perforation.

Authors:  D D DAVIES
Journal:  Br Med J       Date:  1957-02-02

4.  Acute peripheral circulatory failure in surgical cases; treatment with 1-noradrenaline.

Authors:  H D RITCHIE
Journal:  Br Med J       Date:  1956-02-18

5.  Dopamine in the treatment of heart failure.

Authors:  A J Miller
Journal:  Proc R Soc Med       Date:  1977

6.  Levarterenol (levophed) therapy in acute myocardial infarction; including case report of recovery following unusually high concentration.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1956-12-01       Impact factor: 8.262

7.  Levarterenol (levophed) therapy in acute myocardial infarction.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1960-04-30       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.